- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02860871
Use of Infrared Spectroscopy in Septic Arthritis Diagnosis (SynoFAST)
April 24, 2017 updated by: Rennes University Hospital
The main objective of this study is to assess the ability of Fiber-optic Evanescent Wave Spectroscopy (FEWS) to discriminate synovial fluids samples of septic arthritis patients from other causes of joint effusion by analyzing ex vivo joint fluid samples collected during routine clinical care.
Study Overview
Study Type
Observational
Enrollment (Actual)
611
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Rennes, France, 35033
- CHU de Rennes
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
patients benefiting from joint fluid puncture for diagnostic purposes in the rheumatology hospitals participating in the study
Description
Inclusion Criteria:
- patients benefiting from joint fluid puncture for diagnostic purposes in the rheumatology hospitals participating in the study
- patients over 18 year old,
- patients who received information about the protocol and have not expressed opposition to participate.
Exclusion Criteria:
- patients opposing the study,
- patients aged below 18 year old
- Protected major (safeguard justice , trusteeship and guardianship) and persons deprived of liberty
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Diagnosis of the cause of joint effusion
Time Frame: through study completion, an average of 6 months
|
The final diagnosis of the cause of joint effusion is made by the clinician based on the clinical and laboratory data : septic arthritis or other causes of arthritis.
|
through study completion, an average of 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2014
Primary Completion (Actual)
August 1, 2016
Study Completion (Actual)
December 1, 2016
Study Registration Dates
First Submitted
July 25, 2016
First Submitted That Met QC Criteria
August 4, 2016
First Posted (Estimate)
August 9, 2016
Study Record Updates
Last Update Posted (Actual)
April 25, 2017
Last Update Submitted That Met QC Criteria
April 24, 2017
Last Verified
July 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 35RC13_8815
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Joint Effusion
-
Temple UniversityCompletedEffusion JointUnited States
-
Duke UniversityRecruitingKnee Osteoarthritis | Knee InjuriesUnited States
-
The Catholic University of KoreaCompleted
-
Rennes University HospitalCompleted
-
Centre Hospitalier le MansCompletedArthritis | Joint Effusion | Septic ArthritisFrance
-
The Catholic University of KoreaCompleted
-
Yazan Saleh Rajab HammadCompletedArthroplasty Complications | HematomaJordan
-
Colorado Joint ReplacementRecruitingEffusion JointUnited States
-
Chinese University of Hong KongRecruitingPericardial Effusion MalignantHong Kong
-
Naestved HospitalTerminatedMalignant Pleural Effusion | Exudative Pleural EffusionDenmark
Clinical Trials on infrared spectroscopy
-
Rennes University HospitalCompleted
-
University of California, IrvineBeckman Laser Institute University of California Irvine; Brooke Army Medical...CompletedHemorrhagic ShockUnited States
-
Zekai Tahir Burak Women's Health Research and Education...UnknownAnemic Preterms, Cerebral Oxygenation,Somatic Oxygenation,Blood TransfusionTurkey
-
Tel-Aviv Sourasky Medical CenterNot yet recruiting
-
National Cerebral and Cardiovascular CenterRecruiting
-
Chinese University of Hong KongNot yet recruitingTraumatic Brain Injury | Intracerebral HemorrhageHong Kong
-
Medical College of WisconsinMarquette UniversityRecruitingEpilepsies, PartialUnited States
-
University of Kansas Medical CenterCompleted
-
Queen's UniversityCompletedSepsis | Delirium | Critical Illness | Respiratory FailureCanada
-
University Hospital, GrenobleCompleted